Literature DB >> 1981323

Lithium and the renal response to gludopa, fenoldopam and dopamine.

A R Girbes, A J Smit, S Meijer, W D Reitsma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981323      PMCID: PMC1368263          DOI: 10.1111/j.1365-2125.1990.tb03831.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Lithium does not reduce the natriuretic response to dopamine in man.

Authors:  D F Schoors; A G Dupont
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

2.  Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release.

Authors:  A Kurtz; R Della Bruna; J Pratz; I Cavero
Journal:  J Cardiovasc Pharmacol       Date:  1988-12       Impact factor: 3.105

3.  Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.

Authors:  H O Ventura; F H Messerli; E D Frohlich; I Kobrin; W Oigman; F G Dunn; R M Carey
Journal:  Circulation       Date:  1984-06       Impact factor: 29.690

4.  Lithium and the kidney.

Authors:  I Singer
Journal:  Kidney Int       Date:  1981-02       Impact factor: 10.612

5.  Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.

Authors:  F Montier; P Katchadourian; J Pratz; I Cavero
Journal:  J Cardiovasc Pharmacol       Date:  1989-05       Impact factor: 3.105

6.  The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.

Authors:  R F Jeffrey; T M Macdonald; J Brown; P W Rae; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

7.  Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release.

Authors:  I Antonipillai; M I Broers; D Lang
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

8.  Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.

Authors:  Z Glück; L Jossen; P Weidmann; M P Gnädinger; E Peheim
Journal:  Hypertension       Date:  1987-07       Impact factor: 10.190

9.  The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.

Authors:  N L Allison; J W Dubb; J A Ziemniak; F Alexander; R M Stote
Journal:  Clin Pharmacol Ther       Date:  1987-03       Impact factor: 6.875

10.  Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.

Authors:  M B Murphy; C E McCoy; R R Weber; E D Frederickson; F L Douglas; L I Goldberg
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.